MEPs ask EU to require full transparency from pharma corporations in the R&D process for new #COVID19 medical tools to ensure all access and availability conditions for funding are met. @Europarl_EN @EUScienceInnov @IMI_JU @EU_HealthRead their...

Medicines shouldn’t be a luxury